All Posts Tagged With: "ABC"
(CAH) Cardinal Health Analyst Maintains Outperform on Shares
We reiterate our Outperform rating on Cardinal Health (CAH). Its first-quarter fiscal 2012 (ended September 30) adjusted earnings per share of 73 cents beat the Zacks Consensus Estimate of 72 cents. Earnings from continuing operations (as reported) dropped about 19% year over...
7Dec2011 | vitalstocks | 0 comments | Continued(ABC) AmerisourceBergen Analyst Reiterates Neutral on Shares
We recently reiterated our Neutral recommendation on AmerisourceBergen Corporation (ABC) with a target price of $40.00. Over the last several years, the company has been benefiting from the growth of the pharmaceutical industry in the US. We believe AmerisourceBergen should continue...
26Aug2011 | vitalstocks | 0 comments | Continued(BIOS) BioScrip Analyst Maintains Neutral Rating on Shares
We maintain our Neutral recommendation on BioScrip Inc. (BIOS) with a target price of $6.25. BioScrip reported a loss of 4 cents per share in the second quarter of fiscal 2011 compared with the year-ago quarter EPS of 6 cents. However, after deducting the impact of restructuring...
16Aug2011 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Third Quarter 2011 Earnings Preview
Cardinal Health (CAH) is slated to report its third-quarter fiscal 2011 (ending March) results on Thursday, April 28. The company expects earnings per share in the range of $2.54 to $2.60 for fiscal 2011. The current Zacks Consensus Estimate for revenues and earnings for the...
27Apr2011 | vitalstocks | 0 comments | Continued(WPI) Watson Pharmaceuticals Analyst Maintains Neutral Rating on Shares
We recently reaffirmed our Neutral stance on Watson Pharmaceuticals Inc. (WPI) following the release of fourth quarter and fiscal year 2010 financial results. Quarterly earnings of 93 cents per share were in line with the Zacks Consensus Estimate and 8 cents above the year-ago...
17Mar2011 | vitalstocks | 0 comments | Continued(ABC) Publishing Industry Outlook – February 2011 – Industry Outlook
The publishing industry had long been grappling with sinking advertising revenue, which was exacerbated by the global economic meltdown. This reflected a longer-term secular decline as more readers get news free online, thereby making the print-advertising model increasingly...
18Feb2011 | vitalstocks | 0 comments | Continued(BIOS) BioScrip Analyst Reaffirms Shares at Neutral
We maintain our Neutral recommendation on BioScrip Inc. (BIOS) following its tepid third-quarter fiscal 2010 results. Earnings for the quarter trailed both the Zacks Consensus Estimate and the year-ago earnings. Profit plummeted 66% year over year, hit by higher costs and tax. On...
27Dec2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Gets Antitrust Clearance
Cardinal Health (CAH) recently announced that antitrust regulators had cleared its $1.3 billion takeover of Kinray, a leading pharma distributor with a presence in the New York metropolitan area. In this regard, the Federal Trade Commission (“FTC”) had approved early termination...
20Dec2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Announces Buy of Kinray
Cardinal Health (CAH) recently announced plans to purchase Kinray Inc., a leading pharma distributor with a presence in the New York metropolitan area. The cash deal will enhance Cardinal’s capability to cater to retail independent pharmacies in the northeastern U.S. markets....
19Dec2010 | vitalstocks | 0 comments | Continued(AAPL) Company News For December 14, 2010 – Corporate Summary
• Pfizer (NYSE:PFE) announced a quarterly dividend increase of 11% to $0.20 • Sanderson Farms (NASDAQ:SAFM) reported fiscal fourth quarter earnings of $2.08, beating Zacks Consensus Estimate of $1.69, on revenues of $529.1 million, which was ahead of Zacks Consensus Estimate...
14Dec2010 | vitalstocks | 0 comments | Continued(ABC) Publishing Industry Outlook – November 2010
The publishing industry has long been grappling with sinking advertising revenue, and the recent global economic meltdown has worsened the situation. This comes in the wake of a longer-term secular decline as more readers choose to get news free online, thereby making the print-advertising...
12Nov2010 | vitalstocks | 0 comments | Continued(ABC) Company News for November 2, 2010 – Corporate Summary
• Pfizer’s (NYSE:PFE) reported third quarter earnings of $0.54, $0.03 above Zacks estimates as revenues surged 39.2% to $16.2 billion, slightly below Zacks estimates of $16.62 billion • Archer Daniels Midland (NYSE:ADM) posted fiscal first quarter earnings of $0.54,...
2Nov2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Prepares for Coming Flu Season
Cardinal Health (CAH) is taking necessary steps to maintain the supply of influenza vaccines during the forthcoming 2010-2011 flu season. For the first time, the Advisory Committee on Immunization Practices (ACIP) has been asking everyone over 6 months of age to get a flu vaccine....
3Oct2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Sells Remaining CareFusion Shares
Cardinal Health (CAH), a leading distributor of pharmaceuticals and medical supplies, recently sold off the remaining 30.5 million shares of CareFusion Corporation (CFN) for $705.9 million. CareFusion, a San Diego-based vendor for medical equipment and infection control supplies,...
19Sep2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health and Cumberland Pharmaceuticals Sign Deal
Cardinal Health (CAH), one of the largest distributors of pharmaceuticals and medical supplies, has reportedly inked a distribution agreement with Nashville, Tennessee-based Cumberland Pharmaceuticals (CPIX), a specialty pharmaceutical firm focused on the acute-care hospital...
22Aug2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health and Cumberland Pharmaceuticals Sign Deal
Cardinal Health (CAH), one of the largest distributors of pharmaceuticals and medical supplies, has reportedly inked a distribution agreement with Nashville, Tennessee-based Cumberland Pharmaceuticals (CPIX), a specialty pharmaceutical firm focused on the acute-care hospital...
18Aug2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Earnings Scorecard
Cardinal Health (CAH), one of the largest distributors of pharmaceuticals and medical supplies, recently reported earnings for fourth-quarter of fiscal year 2010, which beat the Zacks Consensus Estimate by a penny. Revenues grew by a mere 0.5% year over year to $22.3 billion....
11Aug2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Analyst Reaffirms Neutral Rating
We maintain our Neutral recommendation for Cardinal Health (CAH), one of the largest distributors of pharmaceuticals and medical supplies. Earnings for fourth-quarter fiscal 2010 beat the Zacks Consensus Estimate by a penny. However, profit dipped year-over-year, impacted by...
10Aug2010 | vitalstocks | 0 comments | Continued(ABT) Pharma and Biotech Industry Outlook – July 2010 – Analyst Interviews
The pharmaceutical industry has witnessed major changes over the past few quarters, with performance being affected by factors like sluggish prescription trends, intensifying generic competition and limited late-stage catalysts. The next five years are expected to reflect a significant...
26Jul2010 | vitalstocks | 0 comments | Continued(ABT) Pharma and Biotech Industry Outlook – July 2010 – Industry Outlook
The pharmaceutical industry has witnessed major changes over the past few quarters, with performance being affected by factors like sluggish prescription trends, intensifying generic competition and limited late-stage catalysts. The next five years are expected to reflect a significant...
20Jul2010 | vitalstocks | 0 comments | Continued(ABC) Publishing Industry Review and Outlook – July 2010 – Industry Outlook
The publishing industry has long been grappling with sinking advertising revenue, and the recent global economic meltdown has worsened the situation. This comes in the wake of a longer-term secular decline as more readers choose to get news free online, thereby making the print-advertising...
6Jul2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Quarterly Earnings Outperform
Cardinal Health, Inc. (CAH) reported third quarter fiscal 2010 earnings per share of 61 cents, outperforming the Zacks Consensus Estimate of 57 cents. However, earnings were lower than the year-ago figure of 66 cents. Sales Total sales in the third quarter increased 1% year over...
30Apr2010 | vitalstocks | 0 comments | Continued(ABC) AmerisourceBergen Beats Forecasts – Raises Outlook Again
AmerisourceBergen Corp. (ABC) posted second quarter fiscal 2010 earnings of 63 cents per share, beating the Zacks Consensus Estimate by 8 cents. Earnings increased 34% from the year-ago period. Performance was driven by strong revenues, successful generic drug launches, and continued...
22Apr2010 | vitalstocks | 0 comments | Continued(ABC) Publishing Industry Outlook – April 2010 – Stock Review
The publishing industry has long been grappling with sinking advertising revenue, and the recent global economic meltdown has worsened the situation. This comes in the wake of a longer-term secular decline as more readers choose to get news free online, thereby making the print-advertising...
1Apr2010 | vitalstocks | 0 comments | Continued(PBR) U.S. Consumer Price Index Remains Tame
We got more evidence today that inflation is not a serious concern. The Consumer Price Index (CPI) was unchanged in February after five straight months when it had increased by only 0.2% per month. Overall consumer prices are just 2.1% higher than a year ago. If food and energy...
18Mar2010 | vitalstocks | 0 comments | Continued(ABC) AmerisourceBergen Corporation Reports Robust Quarterly Results
AmerisourceBergen Corporation (ABC) recently declared a dividend of 8 cents per share. The company pays an industry-leading dividend yield of 1.13%. In late January, the company reported record earnings of 52 cents for the fiscal first quarter, topping the Zacks Consensus Estimate...
5Feb2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Beats Expectations and Boosts Estimates
Cardinal Health, Inc. (CAH) reported second quarter fiscal 2010 earnings per share of 57 cents, surpassing the Zacks Consensus Estimate of 46 cents and the year-ago earnings of 51 cents. Sales Total sales in the reported quarter increased 3% year over year to $24.9 billion. Growth...
28Jan2010 | vitalstocks | 0 comments | Continued(MCK) McKesson Corporation Reports Earnings in Line With Analysts
McKesson Corp. (MCK) reported fiscal third-quarter earnings of $1.19 per share, in line with the Zacks Consensus Estimate. However, earnings increased 13% from the year-ago profit of $1.05. Meanwhile, revenues increased 4% to $28.3 billion, driven by the strong performance of...
27Jan2010 | vitalstocks | 0 comments | Continued(ABC) AmerisourceBergen Corporation Surpasses Expectations – Ups Outlook
This morning, AmerisourceBergen Corp. (ABC) posted first quarter fiscal 2010 earnings of 52 cents per share, beating the Zacks Consensus Estimate by 6 cents. Earnings increased 44% from the year-ago period. Performance was driven by strong revenues, successful generic drug launches,...
26Jan2010 | vitalstocks | 0 comments | Continued(ABC) AmerisourceBergen Corp Ups Earnings View
AmerisourceBergen Corp. (ABC) increased its earnings expectations for the first quarter of fiscal 2010 and stated that it expects earnings to exceed consensus estimates of 43 cents, mainly due to higher sales of generic drugs. Revenues are expected to grow more than 10% during...
16Dec2009 | vitalstocks | 0 comments | Continued